Reply Journal of Allergy and Clinical Immunology

Slides:



Advertisements
Similar presentations
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Advertisements

Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007 Raymond James Mullins, MBBS, PhD, FRACP, FRCPA, Keith B.G.
Reply Journal of Allergy and Clinical Immunology
Immunomodulatory effects of aqueous birch pollen extracts and phytoprostanes on primary immune responses in vivo  Jan Gutermuth, MD, Mayte Bewersdorff,
Identification of drug- and drug-metabolite immune responses originating from both naive and memory T cells  Andrew Gibson, MRes, Lee Faulkner, PhD, Sally.
Flow cytometry imaging identifies rare TH2 cells expressing thymic stromal lymphopoietin receptor in a “proallergic” milieu  Amanda J. Reefer, MS, Kathryn.
Fatty acids, inflammation, and asthma
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Differential cytokine induction by the human skin–associated autoallergen thioredoxin in sensitized patients with atopic dermatitis and healthy control.
Human B cells promote T-cell plasticity to optimize antibody response by inducing coexpression of TH1/TFH signatures  Jelle de Wit, PhD, Tineke Jorritsma,
Targeting Toll-like receptors on dendritic cells modifies the TH2 response to peanut allergens in vitro  Pierre Pochard, PhD, Brian Vickery, MD, M. Cecilia.
Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: Role of macrophage scavenger receptor class A type I and II 
Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease  Kirandeep.
Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin  Mohan S. Maddur, DVM, Janakiraman Vani,
Is 9 more than 2 also in allergic airway inflammation?
Fatty acids, inflammation, and asthma
Heleen D. de Koning, MD, Joost Schalkwijk, PhD, Jos W. M
Dendritic cells from X-linked hyper-IgM patients present impaired responses to Candida albicans and Paracoccidioides brasiliensis  Otavio Cabral Marques,
Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease  Kirandeep.
Modulation of allergen-specific T-lymphocyte function by virus-like particles decorated with HLA class II molecules  Victoria M. Leb, MSc, Beatrice Jahn-Schmid,
Hospitalization rates and prognosis of patients with anaphylactic shock in Denmark from 1995 through 2012  Anni Nørgaard Jeppesen, MD, Christian Fynbo.
Tolerance-like mediated suppression by mesenchymal stem cells in patients with dust mite allergy–induced asthma  Simi Kapoor, MD, Shyam A. Patel, PhD,
Clara cell 16-kd protein downregulates TH2 differentiation of human naive neonatal T cells  Sofi Johansson, MSc, Göran Wennergren, MD, PhD, Nils Åberg,
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Nonadherence to Asthma Treatment: Getting Unstuck
Etiology of asthma exacerbations
Naturally processed T cell–activating peptides of the major birch pollen allergen  Sonja Mutschlechner, PhD, Matthias Egger, PhD, Peter Briza, PhD, Michael.
René van Gent, MD, Cornelis K. van der Ent, MD, PhD, Maroeska M
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Eszter Herczenik, PhD, Simon D
Role of hyaluronan and hyaluronan-binding proteins in human asthma
β-Agonist enhances type 2 T-cell survival and accumulation
Reply Journal of Allergy and Clinical Immunology
Identification of drug- and drug-metabolite immune responses originating from both naive and memory T cells  Andrew Gibson, MRes, Lee Faulkner, PhD, Sally.
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Jill A. Poole, MD, Neil E. Alexis, PhD, Conrad Parks, BS, Amy K
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma  Benny Dua, MSc, Richard M. Watson, BSc,
Peanut T-cell epitope discovery: Ara h 1
Sabah El-Ghaiesh, MSc, Joseph P
Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1∗01 
Josée Lamoureux, PhD, Jana Stankova, PhD, Marek Rola-Pleszczynski, MD 
What is an “eosinophilic phenotype” of asthma?
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Autophagy: Nobel Prize 2016 and allergy and asthma research
IL-2– and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets  Sven Létourneau, DPhil, Carsten Krieg, PhD, Giuseppe Pantaleo,
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
Luisa Lunardon, MD, Aimee S. Payne, MD, PhD 
Matthew J. Loza, PhD, Susan Foster, PhD, Stephen P
Defining antigen-specific responses with human MHC class II tetramers
Bruce G. Bender, PhD, Alex Pedan, PhD, Laleh T. Varasteh, RPh, MSF 
Epinephrine (adrenaline) absorption from new-generation, taste-masked sublingual tablets: A preclinical study  Ousama Rachid, BPharm, MSc, Mutasem M.
Measles and immunomodulation
Stefan Schülke, PhD, Stefan Vieths, PhD 
Reply Journal of Allergy and Clinical Immunology
CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X- linked–like syndrome, and defective IL-10 expression from CD4 lymphocytes 
IL-10–producing monocytes differentiate to alternatively activated macrophages and are increased in atopic patients  Antje Prasse, MD, Martin Germann,
Human basophils may not undergo modulation by DC-SIGN and mannose receptor– targeting immunotherapies due to absence of receptors  Mrinmoy Das, MSc, Caroline.
Macrolide antibiotics and asthma treatment
Immune pathomechanism of drug hypersensitivity reactions
Asthma: The past, future, environment, and costs
Janet Chou, MD, Maxim Lutskiy, MD, PhD, Erdyni Tsitsikov, PhD, Luigi D
IgG4 production is confined to human IL-10–producing regulatory B cells that suppress antigen-specific immune responses  Willem van de Veen, MSc, Barbara.
Dendritic cells in nasal mucosa of subjects with different allergic sensitizations  Susanne M. Reinartz, MD, Joost van Tongeren, MD, Danielle van Egmond,
Environmental factors and eosinophilic esophagitis
Systemic responses after bronchial aspirin challenge in sensitive patients with asthma  Joanna S. Makowska, MD, PhD, Janina Grzegorczyk, PhD, Barbara Bienkiewicz,
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Presentation transcript:

Reply Journal of Allergy and Clinical Immunology Eszter Herczenik, PhD, Simon D. van Haren, PhD, Aleksandra Wroblewska, MSc, Paul Kaijen, MSc, Maartje van den Biggelaar, PhD, Alexander B. Meijer, PhD, Anja ten Brinke, PhD, Jan Voorberg, PhD  Journal of Allergy and Clinical Immunology  Volume 129, Issue 4, Pages 1174-1175 (April 2012) DOI: 10.1016/j.jaci.2011.12.1004 Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Proliferation of a FVIII C2 domain–specific CD4+ T-cell clone is mannan insensitive. A, Monocytes were isolated from a matched HLA DRB1∗0101/DRB1∗1301 and cultured with 1000 U/mL of GM-CSF and 800 U/mL of IL-4 for 4-7 days as described.1 DCs were first pretreated for 15 minutes with 1 mg/mL of mannan and incubated with 100 nM of FVIII for 1 hour to allow endocytosis. Then the cells were washed twice, resuspended at a concentration of 5 × 103/100 μL, and combined with 5 × 104/100 μL of carboxyfluorescein succinimidyl ester–labeled CD4+ T-cell clone 32A-18, which was derived from a DRB1∗0101-positive hemophilia A patient.2,3 After 6 days of culture, the mean fluorescent intensity of the resuspended CD4+ T cells was measured and the data were analyzed with FlowJo 7.6.4 software (Tree Inc, Ashland, Ore). B, The glycosylation site N2118 in the C1 domain remains distant from the KM33 epitope that includes residues K2092 and F2093. The carbohydrate structure depicted is a core-fucosylated high-mannose structure that was modeled by using the glycam Webserver (http://glycam.ccrc.uga.edu/ccrc/). The image was generated by using the PyMOL Molecular Graphics System, Version 1.3, Schrödinger, LLC (New York, NY). FITC, Fluorescein isothiocyanate. Journal of Allergy and Clinical Immunology 2012 129, 1174-1175DOI: (10.1016/j.jaci.2011.12.1004) Copyright © 2012 American Academy of Allergy, Asthma & Immunology Terms and Conditions